{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:03:10Z","timestamp":1770742990757,"version":"3.49.0"},"reference-count":52,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82360035"],"award-info":[{"award-number":["82360035"]}]},{"name":"National Natural Science Foundation of China","award":["82260854"],"award-info":[{"award-number":["82260854"]}]},{"name":"National Natural Science Foundation of China","award":["82060738"],"award-info":[{"award-number":["82060738"]}]},{"name":"National Natural Science Foundation of China","award":["ZK [2024] 124"],"award-info":[{"award-number":["ZK [2024] 124"]}]},{"name":"National Natural Science Foundation of China","award":["Qian Kehe ZK [2022] 485"],"award-info":[{"award-number":["Qian Kehe ZK [2022] 485"]}]},{"name":"Science and Technology Department of Guizhou Province","award":["82360035"],"award-info":[{"award-number":["82360035"]}]},{"name":"Science and Technology Department of Guizhou Province","award":["82260854"],"award-info":[{"award-number":["82260854"]}]},{"name":"Science and Technology Department of Guizhou Province","award":["82060738"],"award-info":[{"award-number":["82060738"]}]},{"name":"Science and Technology Department of Guizhou Province","award":["ZK [2024] 124"],"award-info":[{"award-number":["ZK [2024] 124"]}]},{"name":"Science and Technology Department of Guizhou Province","award":["Qian Kehe ZK [2022] 485"],"award-info":[{"award-number":["Qian Kehe ZK [2022] 485"]}]},{"name":"Guizhou Provincial Basic Research Program (Natural Science)","award":["82360035"],"award-info":[{"award-number":["82360035"]}]},{"name":"Guizhou Provincial Basic Research Program (Natural Science)","award":["82260854"],"award-info":[{"award-number":["82260854"]}]},{"name":"Guizhou Provincial Basic Research Program (Natural Science)","award":["82060738"],"award-info":[{"award-number":["82060738"]}]},{"name":"Guizhou Provincial Basic Research Program (Natural Science)","award":["ZK [2024] 124"],"award-info":[{"award-number":["ZK [2024] 124"]}]},{"name":"Guizhou Provincial Basic Research Program (Natural Science)","award":["Qian Kehe ZK [2022] 485"],"award-info":[{"award-number":["Qian Kehe ZK [2022] 485"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Acute erythroid leukemia (AEL) is a rare and aggressive hematological malignancy managed with chemotherapy, targeted therapies, and stem cell transplantation. However, these treatments often suffer from limitations such as refractoriness, high toxicity, recurrence, and drug resistance, underscoring the urgent need for novel therapeutic approaches. Dibromo-edaravone (D-EDA) is a synthetic derivative of edaravone (EDA) with unreported anti-leukemic properties. In this study, D-EDA demonstrated potent cytotoxicity against HEL cells with an IC50 value of 8.17 \u00b1 0.43 \u03bcM using an MTT assay. Morphological analysis via inverted microscopy revealed reductions in cell number and signs of cellular crumpling and fragmentation. Flow cytometry analysis, Hoechst 33258 staining, Giemsa staining, a JC-1 assay, and a reactive oxygen species (ROS) assay showed that D-EDA induced apoptosis in HEL cells. Furthermore, D-EDA induced S-phase cell cycle arrest. Western blot analysis showed significant upregulation of key apoptosis-related proteins, including cleaved caspase-9, cleaved caspase-3, and cleaved poly ADP-ribose polymerase (PARP), alongside a reduction in Bcl-2 expression. Additionally, oncogenic markers such as c-Myc, CyclinA2, and CDK2 were downregulated, while the cell cycle inhibitor p21 was upregulated. Mechanistic studies involving molecular docking, a cellular thermal shift assay (CETSA), the caspase inhibitor Z-VAD-FMK, JAK2 inhibitor Ruxolitinib, and STAT3 inhibitor Stattic revealed that D-EDA activates the caspase cascade and inhibits the JAK2-STAT3 signaling pathway in HEL cells. In vivo, D-EDA improved spleen structure, increased the hemolysis ratio, and extended survival in a mouse model of acute erythroleukemia. In conclusion, D-EDA induces apoptosis via the caspase cascade and JAK2-STAT3 signaling pathway, demonstrating significant anti-leukemia effects in vitro and in vivo. Thus, D-EDA may be developed as a potential therapeutic agent for acute erythroleukemia.<\/jats:p>","DOI":"10.3390\/ijms26094000","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T10:40:48Z","timestamp":1745404848000},"page":"4000","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dibromo-Edaravone Induces Anti-Erythroleukemia Effects via the JAK2-STAT3 Signaling Pathway"],"prefix":"10.3390","volume":"26","author":[{"given":"Qiqing","family":"Chen","sequence":"first","affiliation":[{"name":"State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 550014, China"},{"name":"Natural Products Research Center of Guizhou Province, Guiyang 550014, China"},{"name":"College of Pharmacy, Guizhou Medical University, Guiyang 550004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 550014, China"},{"name":"Natural Products Research Center of Guizhou Province, Guiyang 550014, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuenai","family":"Wei","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 550014, China"},{"name":"Natural Products Research Center of Guizhou Province, Guiyang 550014, China"},{"name":"College of Pharmacy, Guizhou Medical University, Guiyang 550004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 550014, China"},{"name":"Natural Products Research Center of Guizhou Province, Guiyang 550014, China"},{"name":"College of Pharmacy, Guizhou Medical University, Guiyang 550004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Tian","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 550014, China"},{"name":"Natural Products Research Center of Guizhou Province, Guiyang 550014, China"},{"name":"College of Pharmacy, Guizhou Medical University, Guiyang 550004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 550014, China"},{"name":"Natural Products Research Center of Guizhou Province, Guiyang 550014, China"},{"name":"College of Pharmacy, Guizhou Medical University, Guiyang 550004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingrui","family":"Song","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 550014, China"},{"name":"Natural Products Research Center of Guizhou Province, Guiyang 550014, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubing","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 550014, China"},{"name":"Natural Products Research Center of Guizhou Province, Guiyang 550014, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wen","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Guizhou Medical University, Guiyang 550004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialei","family":"Song","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Jian","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 550014, China"},{"name":"Natural Products Research Center of Guizhou Province, Guiyang 550014, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmei","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Guizhou Medical University, Guiyang 550014, China"},{"name":"Natural Products Research Center of Guizhou Province, Guiyang 550014, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global burden of hematologic malignancies and evolution patterns over the past 30 years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Fernandes, P., Waldron, N., Chatzilygeroudi, T., Naji, N.S., and Karantanos, T. (2024). Acute Erythroid Leukemia: From Molecular Biology to Clinical Outcomes. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25116256"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11912-021-01060-8","article-title":"Erythroleukemia: An Update","volume":"23","author":"Weinberg","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.clml.2023.04.011","article-title":"A History and Current Understanding of Acute Erythroid Leukemia","volume":"23","author":"Alexander","year":"2023","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41568-021-00355-z","article-title":"Leukaemia: A model metastatic disease","volume":"21","author":"Whiteley","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/1566524021666210121142316","article-title":"Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future","volume":"21","author":"Liao","year":"2021","journal-title":"Curr. Mol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Uchida, H.A., Takatsuka, T., Hada, Y., Umebayashi, R., Takeuchi, H., Shikata, K., Subramanian, V., Daugherty, A., and Wada, J. (2022). Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice. Biomolecules, 12.","DOI":"10.3390\/biom12081117"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/med.21528","article-title":"Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs","volume":"39","author":"Jaiswal","year":"2019","journal-title":"Med. Res. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12974-022-02400-6","article-title":"Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1\/Nrf2\/HO-1\/Gpx4 pathway","volume":"19","author":"Dang","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Duranti, E., Cordani, N., and Villa, C. (2024). Edaravone: A Novel Possible Drug for Cancer Treatment?. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031633"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Jin, W. (2020). Role of JAK\/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition. Cells, 9.","DOI":"10.3390\/cells9010217"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Owen, K.L., Brockwell, N.K., and Parker, B.S. (2019). JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression. Cancers, 11.","DOI":"10.3390\/cancers11122002"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: Autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ni.3691","article-title":"Mechanisms and consequences of Jak\u2013STAT signaling in the immune system","volume":"18","author":"Villarino","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"102390","DOI":"10.1016\/j.autrev.2019.102390","article-title":"JAK inhibitors for the treatment of autoimmune and inflammatory diseases","volume":"18","author":"Jamilloux","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: From bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1158\/1535-7163.MCT-22-0323","article-title":"JAK: Not Just Another Kinase","volume":"21","author":"Agashe","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"100634","DOI":"10.1016\/j.blre.2019.100634","article-title":"JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia","volume":"40","author":"Venugopal","year":"2020","journal-title":"Blood Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1111\/cas.15855","article-title":"Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial\u2013mesenchymal transition-like program in AML through IL-6\/JAK2\/STAT3 signaling","volume":"114","author":"Lu","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/carcin\/bgab075","article-title":"JAK\/STAT of all trades: Linking inflammation with cancer development, tumor progression and therapy resistance","volume":"42","author":"Ryan","year":"2021","journal-title":"Carcinogenesis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Ye, X., Xiong, Z., Ihsan, A., Ares, I., Mart\u00ednez, M., Lopez-Torres, B., Mart\u00ednez-Larra\u00f1aga, M.-R., Anad\u00f3n, A., and Wang, X. (2023). Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells. Metabolites, 13.","DOI":"10.3390\/metabo13070796"},{"key":"ref_23","first-page":"111","article-title":"Mitochondria\u2014The suicide organelles, BioEssays: News and reviews in molecular","volume":"23","author":"Ferri","year":"2001","journal-title":"Cell. Dev. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2147\/JIR.S353489","article-title":"Role of JAK2\/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic Review","volume":"15","author":"Ayele","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Al-Rawashde, F.A., Al-Sanabra, O.M., Alqaraleh, M., Jaradat, A.Q., Al-Wajeeh, A.S., Johan, M.F., Taib, W.R.W., Ismail, I., and Al-Jamal, H.A.N. (2023). Thymoquinone Enhances Apoptosis of K562 Chronic Myeloid Leukemia Cells through Hypomethylation of SHP-1 and Inhibition of JAK\/STAT Signaling Pathway. Pharmaceuticals, 16.","DOI":"10.3390\/ph16060884"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.5858\/2009-0350-RA.1","article-title":"Acute erythroid leukemia","volume":"134","author":"Zuo","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"108579","DOI":"10.1016\/j.pharmthera.2023.108579","article-title":"Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets","volume":"254","author":"Mushtaq","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","article-title":"Cell death","volume":"187","author":"Newton","year":"2024","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ketelut-Carneiro, N., and Fitzgerald, K.A. (2022). Apoptosis, Pyroptosis, and Necroptosis\u2014Oh My! The Many Ways a Cell Can Die. J. Mol. Biol., 434.","DOI":"10.1016\/j.jmb.2021.167378"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Gieleci\u0144ska, A., Kciuk, M., Yahya, E.-B., Ainane, T., Mujwar, S., and Kontek, R. (2023). Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents?. Biochim. Biophys. Acta (BBA)\u2014Rev. Cancer, 1878.","DOI":"10.1016\/j.bbcan.2023.189024"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: An intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1016\/j.csbj.2021.07.038","article-title":"From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways","volume":"19","author":"Wang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","article-title":"Mechanisms of BCL-2 family proteins in mitochondrial apoptosis","volume":"24","author":"Czabotar","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1078\/0065-1281-00601","article-title":"The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition","volume":"103","year":"2001","journal-title":"Acta Histochem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.tcb.2022.03.010","article-title":"Mechanical regulation of cell-cycle progression and division","volume":"32","author":"Gupta","year":"2022","journal-title":"Trends Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ligasov\u00e1, A., Frydrych, I., and Koberna, K. (2023). Basic Methods of Cell Cycle Analysis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043674"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Uzbekov, R., and Prigent, C. (2022). A Journey through Time on the Discovery of Cell Cycle Regulation. Cells, 11.","DOI":"10.3390\/cells11040704"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"114840","DOI":"10.1016\/j.ecoenv.2023.114840","article-title":"Phytosphingosine inhibits cell proliferation by damaging DNA in human cell lines","volume":"256","author":"Sun","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41375-021-01451-7","article-title":"p21-Activated kinases as promising therapeutic targets in hematological malignancies","volume":"36","author":"Wu","year":"2022","journal-title":"Leukemia"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Llombart, V., and Mansour, M.R. (2022). Therapeutic targeting of \u201cundruggable\u201d MYC. eBioMedicine, 75.","DOI":"10.1016\/j.ebiom.2021.103756"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","article-title":"The JAK-STAT pathway at 30: Much learned, much more to do","volume":"185","author":"Philips","year":"2022","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e12974","DOI":"10.1111\/cpr.12974","article-title":"STAT3 and its targeting inhibitors in osteosarcoma","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12943-023-01929-1","article-title":"JAK\/STAT in leukemia: A clinical update","volume":"23","author":"Liang","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Fasouli, E.S., and Katsantoni, E. (2021). JAK-STAT in Early Hematopoiesis and Leukemia. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.669363"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1182\/blood.2022017416","article-title":"Biology and therapeutic targeting of molecular mechanisms in MPNs","volume":"141","author":"How","year":"2023","journal-title":"Blood"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"106362","DOI":"10.1016\/j.phrs.2022.106362","article-title":"Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders","volume":"183","author":"Roskoski","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00894-025-06281-3","article-title":"Stattic suppresses p-STAT3 and induces cell death in T-cell acute lymphoblastic leukemia","volume":"31","author":"Li","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"He, Y., Zhang, H., Zhang, X., Han, Y., Duan, H., Song, W., Tian, Q., Wang, Y., Li, G., and Wu, C. (2024). Eleutheroside B alleviates oxidative stress and neuroinflammation by inhibiting the JAK2\/STAT3 signaling pathway in a rat high altitude cerebral edema model. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1506483"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1073\/pnas.87.4.1332","article-title":"Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus","volume":"87","author":"Giddens","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Wang, C., Wang, B., Mou, Y., Liu, X., Chen, Q., Pu, W., Rao, Q., Wang, C., Song, J., and Huang, Y. (2024). Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras\/Raf\/MEK\/ERK and STAT3\/c-Myc Pathways. Molecules, 29.","DOI":"10.3390\/molecules29071597"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/4000\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:20:22Z","timestamp":1760030422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/4000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":52,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26094000"],"URL":"https:\/\/doi.org\/10.3390\/ijms26094000","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]}}}